Selected article for: "clinical assessment and lung function"

Author: Mantovani, Elisa; Mariotto, Sara; Gabbiani, Daniele; Dorelli, Gianluigi; Bozzetti, Silvia; Federico, Angela; Zanzoni, Serena; Girelli, Domenico; Crisafulli, Ernesto; Ferrari, Sergio; Tamburin, Stefano
Title: Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?
  • Cord-id: n7oankiq
  • Document date: 2021_8_2
  • ID: n7oankiq
    Snippet: SARS-CoV-2 survivors may report persistent symptoms that resemble myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). We explored (a) ME/CFS-like symptom prevalence and (b) whether axonal, inflammatory, and/or lung changes may contribute to ME/CFS-like symptoms in SARS-CoV-2 survivors through clinical, neuropsychiatric, neuropsychological, lung function assessment, and serum neurofilament light chain, an axonal damage biomarker. ME/CFS-like features were found in 27% of our sample. ME/C
    Document: SARS-CoV-2 survivors may report persistent symptoms that resemble myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). We explored (a) ME/CFS-like symptom prevalence and (b) whether axonal, inflammatory, and/or lung changes may contribute to ME/CFS-like symptoms in SARS-CoV-2 survivors through clinical, neuropsychiatric, neuropsychological, lung function assessment, and serum neurofilament light chain, an axonal damage biomarker. ME/CFS-like features were found in 27% of our sample. ME/CFS-like group showed worse sleep quality, fatigue, pain, depressive symptoms, subjective cognitive complaints, Borg baseline dyspnea of the 6-min walking test vs. those without ME/CFS-like symptoms. These preliminary findings raise concern on a possible future ME/CFS-like pandemic in SARS-CoV-2 survivors.

    Search related documents:
    Co phrase search for related documents